B

Bright Minds Biosciences Inc
CNSX:DRUG

Watchlist Manager
Bright Minds Biosciences Inc
CNSX:DRUG
Watchlist
Price: 58.27 CAD -1.24% Market Closed
Market Cap: 260.1m CAD
Have any thoughts about
Bright Minds Biosciences Inc?
Write Note

Bright Minds Biosciences Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bright Minds Biosciences Inc
Net Income Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
B
Bright Minds Biosciences Inc
CNSX:DRUG
Net Income
-CA$7.4m
CAGR 3-Years
-149%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Net Income
-$3.2m
CAGR 3-Years
51%
CAGR 5-Years
15%
CAGR 10-Years
10%
Repare Therapeutics Inc
NASDAQ:RPTX
Net Income
-$93.8m
CAGR 3-Years
-21%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Net Income
-$22.6m
CAGR 3-Years
47%
CAGR 5-Years
18%
CAGR 10-Years
-4%
Covalon Technologies Ltd
XTSX:COV
Net Income
-CA$823.4k
CAGR 3-Years
25%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Net Income
-CA$25.1m
CAGR 3-Years
-44%
CAGR 5-Years
-53%
CAGR 10-Years
-9%

See Also

What is Bright Minds Biosciences Inc's Net Income?
Net Income
-7.4m CAD

Based on the financial report for Sep 30, 2023, Bright Minds Biosciences Inc's Net Income amounts to -7.4m CAD.

What is Bright Minds Biosciences Inc's Net Income growth rate?
Net Income CAGR 3Y
-149%

Over the last year, the Net Income growth was 51%. The average annual Net Income growth rates for Bright Minds Biosciences Inc have been -149% over the past three years .

Back to Top